ArticleBiomedicines2025

Comparative Pharmacovigilance Analysis of Approved and Repurposed Antivirals for COVID-19: Insights from EudraVigilance Data.

Paul Andrei Negru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.